ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 11 filers reported holding ZEALAND PHARMA A S in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $544,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 320,719 | $4,817,000 | 0.93% |
| FARALLON CAPITAL MANAGEMENT LLC | 865,000 | $12,992,000 | 0.09% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,938,996 | $29,123,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 170,844 | $2,566,000 | 0.00% |
| Laurion Capital Management LP | 16,617 | $250,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,291 | $19,000 | 0.00% |
| UNITED SERVICES AUTOMOBILE ASSOCIATION | 24,500 | $368,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 10,000 | $150,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 875 | $14,000 | 0.00% |
| MORGAN STANLEY | 2,297 | $35,000 | 0.00% |